Bernhard K. Keppler

37.9k total citations · 9 hit papers
705 papers, 32.3k citations indexed

About

Bernhard K. Keppler is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Bernhard K. Keppler has authored 705 papers receiving a total of 32.3k indexed citations (citations by other indexed papers that have themselves been cited), including 432 papers in Oncology, 304 papers in Organic Chemistry and 184 papers in Molecular Biology. Recurrent topics in Bernhard K. Keppler's work include Metal complexes synthesis and properties (400 papers), Ferrocene Chemistry and Applications (139 papers) and Lanthanide and Transition Metal Complexes (99 papers). Bernhard K. Keppler is often cited by papers focused on Metal complexes synthesis and properties (400 papers), Ferrocene Chemistry and Applications (139 papers) and Lanthanide and Transition Metal Complexes (99 papers). Bernhard K. Keppler collaborates with scholars based in Austria, Germany and Slovakia. Bernhard K. Keppler's co-authors include Michael A. Jakupec, Christian G. Hartinger, M. Galanski, Vladimir B. Arion, Walter Berger, Petra Heffeter, Christian R. Kowol, Andrei R. Timerbaev, Paul J. Dyson and Alexander Roller and has published in prestigious journals such as Nature, Chemical Reviews and Journal of the American Chemical Society.

In The Last Decade

Bernhard K. Keppler

702 papers receiving 31.8k citations

Hit Papers

From bench to bedside – preclinical and early clinic... 1993 2026 2004 2015 2006 2007 2008 2005 1993 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
    2006 860 citations Michael A. Jakupec, Bernhard K. Keppler et al. profile →
  2. Antitumour metal compounds: more than theme and variations
    2007 761 citations Michael A. Jakupec, M. Galanski et al. Dalton Transactions profile →
  3. KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
    2008 732 citations Michael A. Jakupec, Walter Berger et al. profile →
  4. Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches
    2005 631 citations M. Galanski, Michael A. Jakupec et al. Current Medicinal Chemistry profile →
  5. Metal complexes in cancer chemotherapy
    1993 607 citations Bernhard K. Keppler profile →
  6. NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
    2014 583 citations Petra Heffeter, Christian R. Kowol et al. Chemical Science profile →
  7. Interactions of Antitumor Metallodrugs with Serum Proteins:  Advances in Characterization Using Modern Analytical Methodology
    2006 562 citations Andrei R. Timerbaev, Bernhard K. Keppler et al. profile →
  8. Anticancer Activity of Metal Complexes: Involvement of Redox Processes
    2011 439 citations Ute Jungwirth, Christian R. Kowol et al. profile →
  9. Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development
    2017 368 citations Samuel M. Meier, Christopher Gerner et al. profile →

Peers

Bernhard K. Keppler
Peter J. Sadler United Kingdom
Angela Casini Italy
Luigi Messori Italy
Arthur E. Martell United States
Trevor W. Hambley Australia
Zijian Guo China
Rudi van Eldik Germany
Edward I. Solomon United States
Helmut Sigel Switzerland
Chris Orvig Canada
Peter J. Sadler United Kingdom
Bernhard K. Keppler
Citations per year, relative to Bernhard K. Keppler Bernhard K. Keppler (= 1×) peers Peter J. Sadler

Countries citing papers authored by Bernhard K. Keppler

Since Specialization
Citations

This map shows the geographic impact of Bernhard K. Keppler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard K. Keppler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard K. Keppler more than expected).

Fields of papers citing papers by Bernhard K. Keppler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard K. Keppler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard K. Keppler. The network helps show where Bernhard K. Keppler may publish in the future.

Co-authorship network of co-authors of Bernhard K. Keppler

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard K. Keppler. A scholar is included among the top collaborators of Bernhard K. Keppler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard K. Keppler. Bernhard K. Keppler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matczuk, Magdalena, Lena Ruzik, Bernhard K. Keppler, & Andrei R. Timerbaev. (2023). Nanoscale Ion-Exchange Materials: From Analytical Chemistry to Industrial and Biomedical Applications. Molecules. 28(18). 6490–6490. 6 indexed citations
3.
4.
Maier, Thomas, Michaela Hejl, Klaudia Cseh, et al.. (2023). Not the usual suspect – an unexpected organometallic product during the synthesis of cytotoxic platinum(ii) complexes. Dalton Transactions. 52(44). 16326–16335. 1 indexed citations
5.
Gluhcheva, Yordanka, et al.. (2023). Effects of Salinomycin and Deferiprone on Lead-Induced Changes in the Mouse Brain. International Journal of Molecular Sciences. 24(3). 2871–2871. 3 indexed citations
6.
Cseh, Klaudia, Andreas Schweikert, Alexander Roller, et al.. (2023). Anticancer Tungstenocenes with a Diverse Set of (O,O–), (O,S–) and (O,N–) Chelates—A Detailed Biological Study Using an Improved Evaluation via 3D Spheroid Models. Pharmaceutics. 15(7). 1875–1875. 1 indexed citations
7.
Meier, Samuel M., Klaudia Cseh, Sarah Theiner, et al.. (2020). Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids. Metallomics. 12(12). 2121–2133. 38 indexed citations
8.
Hejl, Michaela, Anton A. Legin, Andreas Schweikert, et al.. (2020). Synthesis, Modification, and Biological Evaluation of a Library of Novel Water‐Soluble Thiopyridone‐Based Organometallic Complexes and Their Unexpected (Biological) Behavior. Chemistry - A European Journal. 26(24). 5419–5433. 13 indexed citations
9.
Castro, Silvia Alonso‐de, Dina Baier, Alexander Roller, et al.. (2019). Ruthenium–arene complexes bearing naphthyl-substituted 1,3-dioxoindan-2-carboxamides ligands for G-quadruplex DNA recognition. Dalton Transactions. 48(32). 12040–12049. 26 indexed citations
10.
Cseh, Klaudia, Alexander Roller, Michaela Hejl, et al.. (2019). The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo—A Comparison of O,O‐, S,O‐, and N,N‐Chelate Effects. Chemistry - A European Journal. 26(10). 2211–2221. 10 indexed citations
11.
Hejl, Michaela, Matthias H. M. Klose, Alexander Roller, et al.. (2018). N- and S-donor leaving groups in triazole-based ruthena(ii)cycles: potent anticancer activity, selective activation, and mode of action studies. Dalton Transactions. 47(13). 4625–4638. 19 indexed citations
12.
Dömötör, Orsolya, et al.. (2018). Structural and solution equilibrium studies on half-sandwich organorhodium complexes of (N,N) donor bidentate ligands. New Journal of Chemistry. 42(13). 11174–11184. 19 indexed citations
13.
Enyedy, Éva A., Marc Pignitter, Franz Jirsa, et al.. (2017). β-O-4 type dilignol compounds and their iron complexes for modeling of iron binding to humic acids: synthesis, characterization, electrochemical studies and algal growth experiments. New Journal of Chemistry. 41(20). 11546–11555. 6 indexed citations
14.
Dömötör, Orsolya, Alexander Roller, Michaela Hejl, et al.. (2017). Comparative equilibrium and structural studies of new pentamethylcyclopentadienyl rhodium complexes bearing (O,N) donor bidentate ligands. Journal of Organometallic Chemistry. 846. 287–295. 11 indexed citations
15.
Jakusch, Tamás, Károly Kozma, Éva A. Enyedy, et al.. (2017). Complexes of pyridoxal thiosemicarbazones formed with vanadium(IV/V) and copper(II): Solution equilibrium and structure. Inorganica Chimica Acta. 472. 243–253. 18 indexed citations
16.
Hejl, Michaela, Alexander Roller, Matthias H. M. Klose, et al.. (2016). Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates. Inorganic Chemistry. 56(1). 528–541. 55 indexed citations
17.
Jungwirth, Ute, Johannes Gojo, Gernot Walko, et al.. (2014). Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46. Molecular Cancer Therapeutics. 13(10). 2436–2449. 19 indexed citations
18.
Grgurić‐Šipka, Sanja, Nevenka Gligorijević, Siniša Radulović, et al.. (2011). X-ray structure and cytotoxic activity of a picolinate ruthenium(II)-arene complex. Journal of the Serbian Chemical Society. 76(1). 53–61. 26 indexed citations
19.
Galanski, M., Michael A. Jakupec, & Bernhard K. Keppler. (2005). Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches. Current Medicinal Chemistry. 12(18). 2075–2094. 631 indexed citations breakdown →
20.
Galanski, M., V.B. Arion, Michael A. Jakupec, & Bernhard K. Keppler. (2003). Recent Developments in the Field of Tumor-Inhibiting Metal Complexes. Current Pharmaceutical Design. 9(25). 2078–2089. 452 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter J. Sadler Breakdown of academic impact, for papers by Angela Casini Breakdown of academic impact, for papers by Luigi Messori Breakdown of academic impact, for papers by Arthur E. Martell Breakdown of academic impact, for papers by Trevor W. Hambley Breakdown of academic impact, for papers by Zijian Guo Breakdown of academic impact, for papers by Rudi van Eldik Breakdown of academic impact, for papers by Edward I. Solomon Breakdown of academic impact, for papers by Helmut Sigel Breakdown of academic impact, for papers by Chris Orvig
Rankless by CCL
2026